Prescription neuromodulators that temporarily relax the muscles responsible for expression lines — delivering a smoother, more refreshed appearance while preserving natural movement. Administered by our nurse injectors under physician oversight at medAge Biltmore Park.
All three major neuromodulators — Dysport, Xeomin, and Botox — work by temporarily blocking the nerve signals that cause targeted muscles to contract, softening the expression lines those contractions create. We use Dysport as our primary neuromodulator and Xeomin as our secondary. Your injector will recommend the right product based on your anatomy and treatment area.
Dysport (abobotulinumtoxinA) is a prescription neuromodulator with a well-established long-term safety profile, backed by over 25 years of clinical use worldwide. Patients typically notice results more quickly with Dysport than with other neuromodulators — in clinical studies, more than half of patients saw improvement in as little as 2–3 days. Results in clinical studies lasted up to 5 months.
Dysport has a slightly more diffuse spread pattern, making it particularly well-suited for larger treatment areas. It is one of the most-studied neuromodulators in aesthetic medicine with a 97% patient satisfaction rate in clinical data.
FDA-Approved Aesthetic Indication: Temporary improvement in the appearance of moderate to severe glabellar lines (frown lines between the brows) in adults under 65 years of age. Other areas discussed at consultation.
Xeomin (incobotulinumtoxinA) is a "naked" neuromodulator — formulated without the accessory proteins found in Botox and Dysport. This makes it an excellent option for patients who have developed resistance to other neuromodulators over time, or who prefer a cleaner, additive-free formulation. Onset and duration are comparable to other neuromodulators.
Your injector will recommend Xeomin when it is the better clinical choice for your specific situation — not as a default, but when the anatomy or history calls for it.
FDA-Approved Aesthetic Indication: Temporary improvement in the appearance of moderate to severe glabellar lines (frown lines between the brows) in adults. Other areas discussed at consultation.
Neuromodulators have one FDA-approved cosmetic indication — frown lines between the brows. In clinical practice, our injectors also use them to address many other areas of facial movement. Your consultation will determine which areas are appropriate for your goals and anatomy.
Use of neuromodulators for areas beyond the FDA-approved glabellar line indication is considered off-label use — a standard, legal, and widely practiced approach in aesthetic medicine. Your provider will discuss all treatment areas, risks, and realistic expectations at your consultation.
Before we inject anything, we assess your facial anatomy — muscle strength, movement patterns, and existing asymmetries. Treatment is mapped to your specific face, not a template or a standard protocol.
The goal is a version of your face that looks rested and refreshed — not treated. We preserve natural expression while softening the lines that make you look tired or stressed. The results our patients notice most are the ones nobody else can name.
Every neuromodulator treatment at medAge is performed under physician-designed protocols. Dr. Ellis built the standard that every injector at this practice works to uphold — and Dr. Long supervises all clinical protocols.
Individual results vary. Photos shared with patient consent. Results are not guaranteed.
Book a consultation and we'll walk you through what's possible for your specific concerns, discuss which areas are appropriate for treatment, and be honest about what neuromodulators can and cannot achieve for your goals.
$75 new patient deposit · applied toward your first treatment
Financing available through PatientFi — pay as low as $97/mo. See payment options →